{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T17:16:44Z","timestamp":1648747004828},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,11,3]],"date-time":"2005-11-03T00:00:00Z","timestamp":1130976000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1007\/s10067-005-0072-6","type":"journal-article","created":{"date-parts":[[2005,11,2]],"date-time":"2005-11-02T09:10:00Z","timestamp":1130922600000},"page":"440-442","source":"Crossref","is-referenced-by-count":1,"title":["Management of musculoskeletal complications in endstage renal disease: an update"],"prefix":"10.1007","volume":"25","author":[{"given":"Dharmarajan","family":"Ramaswamy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petros","family":"Efthimiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isaiarasi","family":"Gnanasekharan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Soni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,11,3]]},"reference":[{"issue":"3","key":"72_CR1","first-page":"iii2","volume":"18","author":"WG Goodman","year":"2003","unstructured":"Goodman WG (2003) Medical management of secondary hyperparathyroidism in chronic renal failure. Nephrol Dial Transplant 18(3):iii2\u2013iii8","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"72_CR2","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1046\/j.1523-1755.2001.0590031187.x","volume":"59","author":"WG Goodman","year":"2001","unstructured":"Goodman WG (2001) Recent developments in the management of secondary hyperparathyroidism. Kidney Int 59(3):1187\u20131201","journal-title":"Kidney Int"},{"issue":"5","key":"72_CR3","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ki.1989.277","volume":"36","author":"E Slatopolsky","year":"1989","unstructured":"Slatopolsky E, Weerts C, Norwood K et al (1989) Long-term effects of calcium carbonate and 2.5\u00a0mEq\/liter calcium dialysate on mineral metabolism. Kidney Int 36(5):897\u2013903","journal-title":"Kidney Int"},{"issue":"7","key":"72_CR4","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/jbmr.5650110714","volume":"11","author":"Y Almaden","year":"1996","unstructured":"Almaden Y, Canalejo A, Hernandez A et al (1996) Direct effect of phosphorus on PTH secretion from whole rat parathyroid glands in vitro. J Bone Miner Res 11(7):970\u2013976","journal-title":"J Bone Miner Res"},{"issue":"10","key":"72_CR5","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1681\/ASN.V12102131","volume":"12","author":"S Ganesh","year":"2001","unstructured":"Ganesh S, Stack A, Levin N, Hulbert-Shearon T, Port F (2001) Association of elevated serum PO4, Ca PO4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol October 1, 2001 12(10):2131\u20132138","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"72_CR6","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1046\/j.1523-1755.1998.00875.x","volume":"53","author":"I Mucsi","year":"1998","unstructured":"Mucsi I, Hercz G, Uldall R, Ouwendyk M, Francoeur R, Pierratos A (1998) Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis. Kidney Int 53(5):1399\u20131404","journal-title":"Kidney Int"},{"issue":"7","key":"72_CR7","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/ndt\/15.7.1014","volume":"15","author":"AP Guerin","year":"2000","unstructured":"Guerin AP, London GM, Marchais SJ, Metivier F (2000) Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant July 1, 2000 15(7):1014\u20131021","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"72_CR8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","volume":"62","author":"GM Chertow","year":"2002","unstructured":"Chertow GM, Burke SK, Raggi P (2002) Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62(1):245\u2013252","journal-title":"Kidney Int"},{"key":"72_CR9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/ndt\/17.suppl_10.10","volume":"10","author":"AJ Brown","year":"2002","unstructured":"Brown AJ, Dusso AS, Slatopolsky E (2002) Vitamin D analogues for secondary hyperparathyroidism. Nephrol Dial Transplant 10:10\u201319","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"72_CR10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S8756-3282(97)00002-1","volume":"20","author":"E Brown","year":"1997","unstructured":"Brown E, Hebert S (1997) Calcium receptor regulated parathyroid and renal function. Bone 20(4):303\u2013309","journal-title":"Bone"},{"issue":"3","key":"72_CR11","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/01.ASN.0000050224.03126.AD","volume":"14","author":"L Quarles","year":"2003","unstructured":"Quarles L et al (2003) The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of endstage renal disease. J Am Soc Nephrol 14(3):575\u2013583","journal-title":"J Am Soc Nephrol"},{"issue":"15","key":"72_CR12","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","volume":"350","author":"G Block","year":"2004","unstructured":"Block G et al (2004) Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 350(15):1516\u20131525","journal-title":"N Engl J Med"},{"issue":"2","key":"72_CR13","first-page":"121","volume":"55","author":"G Dzido","year":"2003","unstructured":"Dzido G, Sprague SM (2003) Dialysis-related amyloidosis. Minerva Urol Nefrol 55(2):121\u2013129","journal-title":"Minerva Urol Nefrol"},{"issue":"90001","key":"72_CR14","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1681\/ASN.V13suppl_1s72","volume":"13","author":"G Lonnemann","year":"2002","unstructured":"Lonnemann G, Koch KM (2002) {beta}2-Microglobulin amyloidosis: effects of ultrapure dialysate and type of dialyzer membrane. J Am Soc Nephrol January 1, 2002 13(90001):S72\u2013S77","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"72_CR15","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1046\/j.1523-1755.2003.00235.x","volume":"64","author":"T Abe","year":"2003","unstructured":"Abe T, Uchita K, Orita H et al (2003) Effect of beta(2)-microglobulin adsorption column on dialysis-related amyloidosis. Kidney Int 64(4):1522\u20131528","journal-title":"Kidney Int"},{"issue":"4","key":"72_CR16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1053\/j.arrt.2003.11.003","volume":"10","author":"JF Winchester","year":"2003","unstructured":"Winchester JF, Salsberg JA, Levin NW (2003) Beta-2 microglobulin in ESRD: an in-depth review. Adv Renal Replace Ther 10(4):279\u2013309","journal-title":"Adv Renal Replace Ther"},{"issue":"2","key":"72_CR17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1525-139x.2001.00028.x","volume":"14","author":"MI Jaradat","year":"2001","unstructured":"Jaradat MI, Moe SM (2001) Effect of hemodialysis membranes on beta 2-microglobulin amyloidosis. Semin Dial 14(2):107\u2013112","journal-title":"Semin Dial"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-005-0072-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-005-0072-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-005-0072-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T01:08:44Z","timestamp":1626656924000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-005-0072-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,3]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["72"],"URL":"https:\/\/doi.org\/10.1007\/s10067-005-0072-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,3]]}}}